Insider · CIK 0001805013
William Thomas McLain Jr.
cfoofficer
Files at EMN (EASTMAN CHEMICAL CO). First filing Feb 24, 2025, latest Feb 24, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $198k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EMN: EASTMAN CHEMICAL CO
EMNOct 9, 2026 · close 62.69
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | EMN EASTMAN CHEMICAL CO | MOption exercise Common Stock | +1,963 | $74.46 | $146k | 51,817 | Feb 24, 2025 |
| Feb 21, 2025 | EMN EASTMAN CHEMICAL CO | SOpen-market sale Common Stock | -1,963 | $101.00 | $198k | 49,854 | Feb 24, 2025 |
| Feb 20, 2025 | EMN EASTMAN CHEMICAL CO | AGrant or award Employee Stock Option (right to buy)derivative | +28,919 | $0.00 | $0 | 28,919 | Feb 24, 2025 |
| Feb 20, 2025 | EMN EASTMAN CHEMICAL CO | AGrant or award Restricted Stock Unitsderivative | +5,523 | $0.00 | $0 | 5,523 | Feb 24, 2025 |
| Feb 21, 2025 | EMN EASTMAN CHEMICAL CO | MOption exercise Employee Stock Option (right to buy)derivative | -1,963 | $0.00 | $0 | 0 | Feb 24, 2025 |
| Feb 18, 2025 | EMN EASTMAN CHEMICAL CO | AGrant or award Common Stock | +19,331 | $0.00 | $0 | 56,021 | Feb 20, 2025 |
| Feb 18, 2025 | EMN EASTMAN CHEMICAL CO | FTax withholding Common Stock | -6,167 | $103.47 | $638k | 49,854 | Feb 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.